Myriam Curet McAdams - 10 Dec 2025 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Signature
By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet
Issuer symbol
ISRG
Transactions as of
10 Dec 2025
Net transactions value
-$34,373
Form type
4
Filing time
10 Dec 2025, 18:23:08 UTC
Previous filing
02 Dec 2025
Next filing
02 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Curet Myriam EVP & Chief Medical Officer 1020 KIFER ROAD, SUNNYVALE By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet 10 Dec 2025 0001632901

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $23,857 +104 $229.39 104 10 Dec 2025 Direct F1
transaction ISRG Common Stock Sale $58,230 -104 -100% $559.90 0 10 Dec 2025 Direct F1
holding ISRG Common Stock 353 10 Dec 2025 by Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -104 -6.6% $0.000000 1,467 10 Dec 2025 Common Stock 104 $229.39 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.
F2 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.